International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.
about
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)Dysfunctional breathing and reaching one's physiological limit as causes of exercise-induced dyspnoeaA review of omalizumab for the management of severe asthmaElucidating novel disease mechanisms in severe asthmaEosinophilic bioactivities in severe asthmaToll-Like Receptor 7-Targeted Therapy in Respiratory DiseaseClinical usefulness of mepolizumab in severe eosinophilic asthmaNovel strategies for the treatment of asthmaChallenges in the management of severe allergic asthma in the elderlyClinical asthma phenotypes in the real world: opportunities and challengesThe past, present, and future of monoclonal antibodies to IL-5 and eosinophilic asthma: a review.Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), IranBiomarkers and severe asthma: a critical appraisalTargeted anti-inflammatory therapeutics in asthma and chronic obstructive lung diseaseProfile of lebrikizumab and its potential in the treatment of asthmaPositioning new pharmacotherapies for COPDA summary of the new GINA strategy: a roadmap to asthma controlThe GINA asthma strategy report: what's new for primary care?Bronchial thermoplasty in asthma: current perspectivesDefining severe asthma - an approach to find new therapiesSex differences in asthma and gastroesophageal reflux disease incidence among the World Trade Center Health Program general responder cohortDelivery of RNAi Therapeutics to the Airways-From Bench to BedsideLong-term safety of tiotropium delivered by Respimat® SoftMist™ Inhaler: patient selection and special considerationsSevere asthma: anti-IgE or anti-IL-5?Asthma heterogeneity and severityPerioperative Evaluation of Patients with Pulmonary Conditions Undergoing Non-Cardiothoracic SurgeryAsthma-related deathsTherapeutic interventions in severe asthmaBiomarkers in the Management of Difficult AsthmaEpigenome-modifying tools in asthmaSevere asthma: definition, diagnosis and treatmentAssessment of work-related asthma prevalence, control and severity: protocol of a field studyTrans-basement membrane migration of eosinophils induced by LPS-stimulated neutrophils from human peripheral blood in vitroChallenges in the pharmacological treatment of geriatric asthma.Effects of Age and Disease Severity on Systemic Corticosteroid Responses in Asthma.Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations.Asthma Is More Severe in Older Adults.Targeting patients with asthma for omalizumab therapy: choosing the right patient to get the best value for money.Unrecognised psychopathology in patients with difficult asthma: major mental and personality disorders.Evaluation of the use of Swedish integrated electronic health records and register health care data as support clinical trials in severe asthma: the PACEHR study.
P2860
Q26740215-ACD73E54-C03B-4F16-991C-823DAF28C284Q26740880-F2EABD01-B341-4E18-97B7-7E29F09D24F8Q26741315-EAEF9DA7-75B3-485C-83BB-B80C6639819EQ26741488-3B53F7B5-5C37-485D-9801-DBEF08FCB3EEQ26744175-B9D20B84-74AC-4C0D-8941-D22A34932003Q26745901-8AC9BB80-A40A-424C-A35D-537F3ACE3203Q26746215-EFB9A243-2844-46B9-B5B8-547AEF5D3163Q26748993-AEF116DD-E010-43D6-A147-3B3FB695071EQ26751301-F1AE1FF3-7706-4FDE-A385-BEEE50A9D8B9Q26775236-8198DCFF-A1B8-4966-AF4F-ADD93CB8FA8DQ26775861-B2D33B5F-67D3-4D9F-B0EB-60E576154793Q26777154-373C8CFB-B229-462B-B2C9-F66CD9644286Q26782718-605864FC-333E-4826-85A1-B72EF57EA843Q26786229-96EDC7F1-4C4E-404E-969A-1548FB238ABAQ26797198-4ED543B5-B6DB-424E-9796-860F36D73125Q26798659-A0F03242-3B91-47A4-B2BB-96DC2C74570BQ26799984-D8A52B80-E5D3-4A90-AA3D-98998402710FQ26801700-DBE538B7-5D09-47DF-9110-7464B897638CQ26852643-3EEA4E60-C0DF-4711-96B6-9BE15B88E9DAQ27001054-B1595BE4-743F-4E10-A920-E03880A45C55Q27908425-2622ECE5-349D-4B8C-BB7E-A606AA18070FQ28067306-F6908CC5-44B4-440F-9C4C-FF5E12F29428Q28067579-BED8DB7B-BF0E-4593-BD88-8C6C65EF5CE6Q28071832-628AAEFC-3A5A-47B8-8837-F3C52D9DF2ACQ28072301-890A9FF4-F782-430C-ADA3-BF814662D61CQ28072690-0FD19F7D-3DB9-4F20-A491-783E2EC2CAAFQ28073233-504B0DD5-89AD-4DF4-BE83-93496CF51351Q28079238-6CFF9D2D-6653-4E84-8296-B084005D2830Q28081109-1700F8FD-AEAB-4BDD-BF2A-D88839A2133AQ28083520-DBF67782-4EC2-4D47-B4BD-420C6EE04C7EQ28087332-D0E573E4-039E-4677-9A64-C8C08FA6E84EQ28394329-F181494B-C3A3-4FFE-84B0-2E553E8D0802Q28596831-96E4431D-4431-454C-9EBC-4F052AFBF1DFQ30251770-166A3E68-D5F2-4103-8784-885092D61F75Q30275238-ACFEFD53-3DC3-4551-A4A1-EBB90FD0F88AQ30276073-EBE3F0F5-BD18-4748-B77A-4283130A8A1EQ30278970-AED620BF-3351-421A-967C-665244BFF58FQ30360362-AEB21FE6-C43C-49F1-B910-0D736F2648ACQ30489960-0F7C5F22-6F6C-408E-98EF-BB34FFDE5792Q31142264-59629F1F-6442-43C2-BED3-8B46BC707E1E
P2860
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
International ERS/ATS guidelin ...... nd treatment of severe asthma.
@en
type
label
International ERS/ATS guidelin ...... nd treatment of severe asthma.
@en
prefLabel
International ERS/ATS guidelin ...... nd treatment of severe asthma.
@en
P2093
P50
P1476
International ERS/ATS guidelin ...... nd treatment of severe asthma.
@en
P2093
Andrew Bush
Christopher Brightling
Elisabeth H Bel
Eric D Bateman
Jan L Brozek
Mario Castro
Nizar N Jajour
Pascal Chanez
Peter Gibson
P304
P356
10.1183/09031936.00202013
P577
2013-12-12T00:00:00Z